Fundraising Fox
Mona Ashiya
InvestorGeneral Partner at OrbiMed
New York, New York
Writes $1M – $75M checks · typically $4M
Find your path to Mona
Sign up to see every warm intro you have to Mona
- Paths you didn't know you had: your email and LinkedIn already hold routes to Mona. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Mona Ashiya is a General Partner at OrbiMed, which she joined in 2010. She previously worked on J.P. Morgan's biotechnology equity research team and held positions at the Global Alliance for TB Drug Development and Harvard Business School. She holds a B.A. from the University of California, Berkeley, a Ph.D. in Cellular, Molecular, and Developmental Biology from the University of Pittsburgh, and completed a post-doctoral fellowship at the Dana Farber Cancer Institute.
Invests in
Biotech
Deals · 1
Prevail TherapeuticsBoard seat
via OrbiMed · filed Mar 2018 · $65M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
Sources: SEC Form D filings · curated public sources.
Colleagues at OrbiMed
Network1
Investors connected to Mona in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Mona Ashiya?
- Mona Ashiya is a General Partner at OrbiMed, which she joined in 2010. She previously worked on J.P. Morgan's biotechnology equity research team and held positions at the Global Alliance for TB Drug Development and Harvard Business School. She holds a B.A. from the University of California, Berkeley, a Ph.D. in Cellular, Molecular, and Developmental Biology from the University of Pittsburgh, and completed a post-doctoral fellowship at the Dana Farber Cancer Institute.
- Where does Mona Ashiya work?
- Mona Ashiya is General Partner at OrbiMed.
- What does Mona Ashiya invest in?
- Mona Ashiya invests in Biotech.
- What check size does Mona Ashiya write?
- Mona Ashiya typically writes checks of $1M – $75M.
- What boards does Mona Ashiya sit on?
- Mona Ashiya holds tracked board seats at Prevail Therapeutics, Vanqua Bio.
- What companies has Mona Ashiya invested in?
- Investments tracked here include Disc Medicine, SiteOne Therapeutics, Vanqua Bio, Yarrow.
About this profile. Compiled from public sources — OrbiMed's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights